The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials

Preclinical studies have demonstrated that statins have anticancer properties and act in an additive or synergistic way when combined with anticancer therapy. We conducted this meta-analysis of randomized, controlled phase II or III trials to evaluate the effect of statins added to systemic anticanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Hyun Joo, Kim, Hyeong Su, Kim, Jung Han, Lee, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210992/
https://www.ncbi.nlm.nih.gov/pubmed/30287761
http://dx.doi.org/10.3390/jcm7100325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210992/
https://www.ncbi.nlm.nih.gov/pubmed/30287761
http://dx.doi.org/10.3390/jcm7100325

Ejemplares similares